Sort
11,323 grants matching “glioblastoma”
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
$3,034,910Steven A. Carr · Broad Institute, Inc. · U24 · FY2011 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$3,024,895E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
$3,023,578Steven A. Carr · Broad Institute, Inc. · U24 · FY2014 · CA
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
$3,019,843Steven A. Carr · Broad Institute, Inc. · U24 · FY2013 · CA
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
$3,012,837Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer
$2,998,170William C Hahn · Dana-Farber Cancer Inst · RC2 · FY2010 · CA
Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer
$2,998,132William C Hahn · Dana-Farber Cancer Inst · RC2 · FY2009 · CA
Gene therapy of cancer
$2,934,429Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Radiation Therapy Oncology Group
$2,923,989Walter John Curran · American College Of Radiology · U10 · FY2011 · CA
Understanding Papillomavirus Virion Proteins and Vaccines
$2,845,656John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,832,522E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
New methods to measure and interrupt metabolic fluxes in brain cancer
$2,820,337Daniel R Wahl · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Systems Biology of Diversity in Cancer
$2,815,894Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2014 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,810,976E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,801,934E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Systems Biology of Diversity in Cancer
$2,791,714Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2010 · CA
iTarget: Institute for Biomolecular Targeting
$2,730,000Dean R Madden · Dartmouth College · P20 · FY2016 · GM
Systems Biology of Diversity in Cancer
$2,729,985Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
Systems Biology of Diversity in Cancer
$2,716,373Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
Systems Biology of Diversity in Cancer
$2,702,738Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,680,832E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
Real-Time Stereotactic Mass Spectrometry Tissue Analysis for Intraoperative Neuro
$2,675,875Nathalie Yr Agar · Brigham And Women'S Hospital · DP2 · FY2010 · OD
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management
$2,654,906Susan M Chang · University Of California, San Francisco · P01 · FY2025 · CA
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management
$2,654,906Susan M Chang · University Of California, San Francisco · P01 · FY2024 · CA
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
$2,641,256Darell D Bigner · Duke University · P01 · FY2016 · CA